Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: Insights from the Global Registry of Acute Coronary Events

American Heart Journal

Volumn 160, Issue 5, 2010, Pages 855-861

  Sibbald, Matthew ^a   Yan, Andrew T ^a   Huang, Wei ^b   Fox, Keith A A ^c   Gore, Joel M ^b   Steg, Ph Gabriel ^d   Eagle, Kim A ^e   Brieger, David ^f   Montalescot, Gilles ^g   Goodman, Shaun G ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d INSERM   (France)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^f Department of Microbiology and Infectious Diseases   (Australia)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; CARDIAC PATIENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY RISK; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; SMOKING; ST SEGMENT ELEVATION; VASCULAR DISEASE;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; REGISTRIES; RISK FACTORS; SMOKING; SURVIVAL RATE; TICLOPIDINE; TIME FACTORS;

EID: 78649373563     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.07.026     Document Type: Article

References (23)

1. Yousef A.M., Arafat T., and Bulatova N.R. Smoking behavior modulates pharmacokinetics of orally administered clopidogrel J Clin Pharm Ther 33 2008 439 449
2. Freedman J.E., and Hylek E.M. Clopidogrel, genetics, and drug responsiveness N Engl J Med 360 2009 411 413
3. Mega J.L., Close S.L., and Wiviott S.D. Cytochrome P-450 polymorphisms and response to clopidogrel N Engl J Med 360 2009 354 362
4. Simon T., Verstuyft C., and Mary-Krause M. Genetic determinants of response to clopidogrel and cardiovascular events N Engl J Med 360 2009 363 375
5. Desai N.R., Mega J.L., and Jiang S. Interaction between cigarette smoking and clinical benefit of clopidogrel J Am Coll Cardiol 53 2009 1273 1278
6. Berger J.S., Bhatt D.L., and Steinhubl S.R. Smoking, clopidogrel, and mortality in patients with established cardiovascular disease Circulation 120 2009 2337 2344
7. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes Am Heart J 141 2001 190 199
8. Goodman S.G., Huang W., and Yan A.T. The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes Am Heart J 158 2009 193 201.e1-e5
9. Yan A.T., Steg P.G., and FitzGerald G. Recurrent ischemia across the spectrum of acute coronary syndromes: prevalence and prognostic significance of (re-)infarction and ST-segment changes in a large contemporary registry Int J Cardiol 2010 10.1016/j.ijcard.2009.05.007 available online 28 May 2009
10. Fox K.A., Dabbous O.H., and Goldberg R.J. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) BMJ 333 2006 1091
11. Granger C.B., Goldberg R.J., and Dabbous O. Predictors of hospital mortality in the global registry of acute coronary events Arch Intern Med 163 2003 2345 2353
12. Moscucci M., Fox K.A., and Cannon C.P. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 2003 1815 1823
13. Yusuf S., Zhao F., and Mehta S.R. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
14. Sabatine M.S., Cannon C.P., and Gibson C.M. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med 352 2005 1179 1189
15. COMMIT collaborative group Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomized placebo-controlled trial Lancet 366 2005 1607 1621
16. de Leon J., Diaz F.J., and Rogers T. A pilot study of plasma caffeine concentrations in a US sample of smoker and nonsmoker volunteers Prog Neuropsychopharmacol Biol Psychiatry 27 2003 165 171
17. Kroon L.A. Drug interactions with smoking Am J Health Syst Pharm 64 2007 1917 1921
18. Schrenk D., Brockmeier D., and Morike K. A distribution study of CYP1A2 phenotypes among smokers and nonsmokers in a cohort of healthy Caucasian volunteers Eur J Clin Pharmacol 53 1998 361 367
19. Backman J.T., Schroder M.T., and Neuvonen P.J. Effects of gender and moderate smoking on the pharmacokinetics and effects of the CYP1A2 substrate tizanidine Eur J Clin Pharmacol 64 2008 17 24
20. Carrillo J.A., Herraiz A.G., and Ramos S.I. Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine J Clin Psychopharmacol 23 2003 119 127
21. Hughes A.N., O'Brien M.E., and Petty W.J. Overcoming CYP1A1/1A2 mediated induction of metabolism by escalating erlotinib dose in current smokers J Clin Oncol 27 2009 1220 1226
22. Geisler T., Langer H., and Wydymus M. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation Eur Heart J 27 2006 2420 2425
23. Price M.J., Endemann S., and Gollapudi R.R. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation Eur Heart J 29 2008 992 1000